FDA Puts Off Forest’s Fibromyalgia Drug Milnacipran

For unknown reasons, SSNRI spending weeks in regulatory limbo.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet